Latest filing published 17 Sept 2026 for Tarsus Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Wendy l. Yarno, listed as board member, has filed trades across 8 companies (mainly through SEC (Form 4)), most often in Inovio Pharmaceuticals, Inc., Aratana Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. In total, 35 filings cover trades dated from 4 May 2016 to 15 September 2026.
On the market, this insider has only ever bought: 2 purchases, €86k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants and 20 option exercises.
The newest entry dates from 17 September 2026: an option exercise, in Tarsus Pharmaceuticals, Inc. The clock since the last published purchase (16 August 2017) now reads 3,352 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations